CSU Stock Overview
Provides lactic acid and lactic acid derivatives, other ferment, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Corbion N.V. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €21.80 |
| 52 Week High | €25.60 |
| 52 Week Low | €15.30 |
| Beta | 0.98 |
| 11 Month Change | -10.66% |
| 3 Month Change | 7.92% |
| 1 Year Change | 29.76% |
| 33 Year Change | -47.11% |
| 5 Year Change | n/a |
| Change since IPO | -54.22% |
Recent News & Updates
Recent updates
Shareholder Returns
| CSU | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | -2.7% | -3.9% | -1.2% |
| 1Y | 29.8% | -2.3% | 9.0% |
Return vs Industry: CSU exceeded the German Chemicals industry which returned 2.5% over the past year.
Return vs Market: CSU exceeded the German Market which returned 13.5% over the past year.
Price Volatility
| CSU volatility | |
|---|---|
| CSU Average Weekly Movement | 4.5% |
| Chemicals Industry Average Movement | 4.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: CSU has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: CSU's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1919 | 2,727 | Olivier Rigaud | www.corbion.com |
Corbion N.V. provides lactic acid and lactic acid derivatives, other ferment, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide. It offers ingredient solutions for the food, home and personal care, animal nutrition, supplements, pharmaceuticals, medical devices, and bioplastics markets. The company markets its products through a network of sales offices and distributors.
Corbion N.V. Fundamentals Summary
| CSU fundamental statistics | |
|---|---|
| Market cap | €1.30b |
| Earnings (TTM) | €80.10m |
| Revenue (TTM) | €1.44b |
16.3x
P/E Ratio0.9x
P/S RatioIs CSU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CSU income statement (TTM) | |
|---|---|
| Revenue | €1.44b |
| Cost of Revenue | €1.10b |
| Gross Profit | €341.30m |
| Other Expenses | €261.20m |
| Earnings | €80.10m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 27, 2025
| Earnings per share (EPS) | 1.38 |
| Gross Margin | 23.71% |
| Net Profit Margin | 5.57% |
| Debt/Equity Ratio | 58.5% |
How did CSU perform over the long term?
See historical performance and comparison